Loading resource…

Infectious Diseases Society of America
The Infectious Diseases Society of America (IDSA) aims to deliver timely, evidence-informed guidance on managing antimicrobial-resistant (AMR) infections. This updated guidance document focuses on treatment strategies for infections caused by extended-spectrum β-lactamase–producing Enterobacterales, carbapenem-resistant Enterobacterales, and other difficult-to-treat Gram-negative pathogens. It replaces earlier versions and emphasizes the importance of clinical judgment in applying these recommendations based on individual patient contexts.
No account needed